MSX-122 是一种口服可用的部分 CXCR4 拮抗剂,抑制 CXCR4/CXCL12 相互作用的 IC50 约为 10 nM。MSX-122 具有抗炎和抗转移活性。
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | CXCR1 ↓ ↑ | CXCR2 ↓ ↑ | CXCR4 ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reparixin | ✔ | 99%+ | |||||||||||||||||
SB225002 |
+++
CXCR2, IC50: 22 nM |
99%+ | |||||||||||||||||
Plerixafor |
++
CXCR4, IC50: 44 nM |
99% | |||||||||||||||||
AMD 3465 6HBr | ✔ | 98% | |||||||||||||||||
WZ811 |
++++
CXCR4, EC50: 0.3 nM |
99% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
描述 | MSX-122, a partial antagonist of CXCR4, impedes the CXCR4/CXCL12 interaction with an IC50 of approximately 10 nM. It does not affect cAMP reduction mediated by the ligands CCR3/CCL5 and CCR5/CCL5. At 100 nM, MSX-122 strongly inhibits the invasion of 78% of MDA-MB-231 cells but does not affect T-tropic HIV infection or show activity in calcium flux assays[1]. |
体内研究 | MSX-122 (10 mg/kg, i.p.) reduces inflammation caused by carrageenan and lung fibrosis from bleomycin in mice. At 4 mg/kg, i.p., daily, MSX-122 inhibits metastasis in a breast cancer metastasis animal model, and at 10 mg/kg i.p., daily, it significantly reduces hepatic micrometastases[1]. |
体外研究 | MSX-122, a partial antagonist of CXCR4, impedes the CXCR4/CXCL12 interaction with an IC50 of approximately 10 nM. It does not affect cAMP reduction mediated by the ligands CCR3/CCL5 and CCR5/CCL5. At 100 nM, MSX-122 strongly inhibits the invasion of 78% of MDA-MB-231 cells but does not affect T-tropic HIV infection or show activity in calcium flux assays[1]. |
Concentration | Treated Time | Description | References | |
KYSE150 cells | 100 nM | MSX-122 attenuated the HIF-1α overexpression-induced promotion of migration and invasion in KYSE150 cells | Cancer Sci. 2022 Mar;113(3):926-939 | |
KYSE30 cells | 100 nM | MSX-122 attenuated the HIF-1α overexpression-induced promotion of migration and invasion in KYSE30 cells | Cancer Sci. 2022 Mar;113(3):926-939 |
Administration | Dosage | Frequency | Description | References | ||
BALB/c nude mice | KYSE30-fLuc lung metastasis model | Intraperitoneal injection | 10 mg/kg | Once daily for 14 consecutive days | MSX-122 inhibited the lung metastasis of KYSE30 cells | Cancer Sci. 2022 Mar;113(3):926-939 |
C57BL/6 mice | Radiation-induced lung fibrosis model | Intraperitoneal injection | 10 mg/kg | Daily administration for 20 weeks | To evaluate the inhibitory effect of MSX-122 on radiation-induced pulmonary fibrosis. Results showed that MSX-122 significantly reduced the development of pulmonary fibrosis, while AMD3100 did not show significant suppression. | PLoS One. 2013 Nov 7;8(11):e79768 |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.42mL 0.68mL 0.34mL |
17.10mL 3.42mL 1.71mL |
34.21mL 6.84mL 3.42mL |
CAS号 | 897657-95-3 |
分子式 | C16H16N6 |
分子量 | 292.34 |
SMILES Code | C1(CNC2=NC=CC=N2)=CC=C(CNC3=NC=CC=N3)C=C1 |
MDL No. | MFCD18803971 |
别名 | Q-122 |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, 2-8°C |
溶解方案 |
DMSO: 3 mg/mL(10.26 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|